Laura Digilio

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

A non-inferiority trial comparing two killed, whole cell, oral cholera vaccines (Cholvax vs. Shanchol) in Dhaka, Bangladesh.

A non-inferiority trial comparing two killed, whole cell, oral cholera vaccines (Cholvax vs. Shanchol) in Dhaka, Bangladesh.

Journal: Vaccine

Published: December 24, 2020

The Euvichol story - Development and licensure of a safe, effective and affordable oral cholera vaccine through global public private partnerships.

The Euvichol story - Development and licensure of a safe, effective and affordable oral cholera vaccine through global public private partnerships.

Journal: Vaccine

Published: April 02, 2018

A randomized, observer-blinded, equivalence trial comparing two variations of Euvichol®, a bivalent killed whole-cell oral cholera vaccine, in healthy adults and children in the Philippines.

A randomized, observer-blinded, equivalence trial comparing two variations of Euvichol®, a bivalent killed whole-cell oral cholera vaccine, in healthy adults and children in the Philippines.

Journal: Vaccine

Published: November 21, 2017

Use of oral cholera vaccine as a vaccine probe to define the geographical dimensions of person-to-person transmission of cholera.

Use of oral cholera vaccine as a vaccine probe to define the geographical dimensions of person-to-person transmission of cholera.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: June 06, 2017

Protection against cholera from killed whole-cell oral cholera vaccines: a systematic review and meta-analysis.

Protection against cholera from killed whole-cell oral cholera vaccines: a systematic review and meta-analysis.

Journal: The Lancet. Infectious diseases

Published: February 14, 2017

Lessons learnt from 12 oral cholera vaccine campaigns in resource-poor settings.

Lessons learnt from 12 oral cholera vaccine campaigns in resource-poor settings.

Journal: Bulletin of the World Health Organization

Published: September 02, 2016

Comparison of immune responses to a killed bivalent whole cell oral cholera vaccine between endemic and less endemic settings.

Comparison of immune responses to a killed bivalent whole cell oral cholera vaccine between endemic and less endemic settings.

Journal: Tropical medicine & international health : TM & IH

Published: December 19, 2015

Potential for Controlling Cholera Using a Ring Vaccination Strategy: Re-analysis of Data from a Cluster-Randomized Clinical Trial.

Potential for Controlling Cholera Using a Ring Vaccination Strategy: Re-analysis of Data from a Cluster-Randomized Clinical Trial.

Journal: PLoS medicine

Published: October 30, 2015

Safety and immunogenicity of a measles, mumps, rubella and varicella vaccine given with combined Haemophilus influenzae type b conjugate/hepatitis B vaccines and combined diphtheria-tetanus-acellular pertussis vaccines.

Safety and immunogenicity of a measles, mumps, rubella and varicella vaccine given with combined Haemophilus influenzae type b conjugate/hepatitis B vaccines and combined diphtheria-tetanus-acellular pertussis vaccines.

Journal: The Pediatric infectious disease journal

Published: March 29, 2006

Evaluation of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children.

Evaluation of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children.

Journal: The Pediatric infectious disease journal

Published: August 12, 2005

Showing 1-10 of 10

Last Updated: 09/26/2026